Showing search results for "Furuichi K"
Drug Discovery Research, Astellas Pharma, Inc., Tsukuba-shi, Ibaraki, Japan
, Lead, Apoptosis, Cancer, Concentration,
, Interleukin, Cancers, Identification, Biopsy,
, Mortality, Patients
Information and abstracts for author publications
Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.
Molecular & cellular proteomics : MCP
Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin.
Biochemical and biophysical research communications
Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.
Construction of a Multilayered Mesenchymal Stem Cell Sheet with a 3D Dynamic Culture System
Construction of a Multilayered…
Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
Scalable Fabrication of Stretc…
Detection of Heterodimerization of Protein Isoforms Using an
Proximity Ligation Assay
Detection of Heterodimerizatio…
Preparation of Chloroplast Sub-compartments from Arabidopsis for the Analysis of Protein Localization by Immunoblotting or Proteomics
Preparation of Chloroplast Sub…
Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture (CARIC) Strategy
Capture and Identification of …
Model for the Evaluation of Endoscopic Submucosal Injection Material Performance
Time-lapse 3D Imaging of Phagocytosis by Mouse Macrophages
Time-lapse 3D Imaging of Phago…
Approaches to Determine Intestinal Epithelial Cell Permeability
Real-time Imaging and Quantification of Fungal Biofilm Development Using a Two-Phase Recirculating Flow System
Real-time Imaging and Quantifi…
JoVE subscription required to view articles
Related JoVE Videos